title: Defects in DNA degradation revealed in crystal structures of TREX1 exonuclease mutations linked to autoimmune disease.
abstract: Mutations within the human TREX1 3' exonuclease are associated with Aicardi-Goutières Syndrome (AGS) and familial chilblain lupus (FCL). Both AGS and FCL are autoimmune diseases that result in increased levels of interferon alpha and circulating antibodies to DNA. TREX1 is a member of the endoplasmic reticulum (ER)-associated SET complex and participates in granzyme A-mediated cell death to degrade nicked genomic DNA. The loss of TREX1 activity may result in the accumulation of double-stranded DNA (dsDNA) degradation intermediates that trigger autoimmune activation. The X-ray crystal structures of the TREX1 wt apoprotein, the dominant D200H, D200N and D18N homodimer mutants derived from AGS and FCL patients, as well as the recessive V201D homodimer mutant have been determined. The structures of the D200H and D200N mutant proteins reveal the enzyme has lost coordination of one of the active site metals, and the catalytic histidine (H195) is trapped in a conformation pointing away from the active site. The TREX1 D18N and V201D mutants are able to bind both metals in the active site, but with inter-metal distances that are larger than optimal for catalysis. Additionally, all of the mutant structures reveal a reduced mobility in the catalytic histidine, providing further explanation for the loss of catalytic activity. The structures of the mutant TREX1 proteins provide insight into the dysfunction relating to human disease. Additionally, the TREX1 apoprotein structure together with the previously determined wild type substrate and product structures allow us to propose a distinct mechanism for the TREX1 exonuclease.
authors.affiliation: Department of Biochemistry, Center for Structural Biology, Wake Forest University Health Sciences, Winston-Salem, NC 27157, United States.
authors.forename: Suzanna L
authors.initials: SL
authors.lastname: Bailey
authors.forename: Scott
authors.initials: S
authors.lastname: Harvey
authors.forename: Fred W
authors.initials: FW
authors.lastname: Perrino
authors.forename: Thomas
authors.initials: T
authors.lastname: Hollis
mesh_terms: D000818:Animals; D001059:Apoproteins / Q000737:chemistry / Q000378:metabolism; D001327:Autoimmune Diseases / Q000201:enzymology* / Q000235:genetics*; D020134:Catalytic Domain; D018360:Crystallography, X-Ray; D004249:DNA Damage; D004795:Enzyme Stability; D005090:Exodeoxyribonucleases / Q000737:chemistry* / Q000235:genetics*; D006801:Humans; D006868:Hydrolysis; D008670:Metals / Q000378:metabolism; D051379:Mice; D008958:Models, Molecular; D050505:Mutant Proteins / Q000737:chemistry / Q000378:metabolism; D009154:Mutation / Q000235:genetics*; D009696:Nucleic Acids / Q000378:metabolism; D010750:Phosphoproteins / Q000737:chemistry* / Q000235:genetics*; D017433:Protein Structure, Secondary
chemical_list: D001059:Apoproteins; D008670:Metals; D050505:Mutant Proteins; D009696:Nucleic Acids; D010750:Phosphoproteins; D005090:Exodeoxyribonucleases; C429526:three prime repair exonuclease 1
references.citation: J Mol Med (Berl). 2007 May;85(5):531-7
references.pmid: 17440703
references.citation: Nat Genet. 2007 Sep;39(9):1065-7
references.pmid: 17660818
references.citation: Chem Biol. 1999 Dec;6(12):901-8
references.pmid: 10631518
references.citation: Dev Med Child Neurol. 2008 Jun;50(6):410-6
references.pmid: 18422679
references.citation: Dermatology. 2009;219(2):162-6
references.pmid: 19478477
references.citation: Am J Hum Genet. 2007 Apr;80(4):811-5
references.pmid: 17357087
references.citation: J Appl Crystallogr. 2007 Aug 1;40(Pt 4):658-674
references.pmid: 19461840
references.citation: EMBO J. 1991 Jan;10(1):25-33
references.pmid: 1989886
references.citation: Nat Struct Mol Biol. 2008 Nov;15(11):1228-31
references.pmid: 18953336
references.citation: J Biol Chem. 2001 May 18;276(20):17022-9
references.pmid: 11279105
references.citation: Acta Crystallogr D Biol Crystallogr. 2006 Apr;62(Pt 4):439-50
references.pmid: 16552146
references.citation: Clin Rheumatol. 2008 Oct;27(10):1341
references.pmid: 19125230
references.citation: EMBO J. 2006 May 3;25(9):1924-33
references.pmid: 16601679
references.citation: Nat Struct Biol. 1998 Oct;5(10):910-6
references.pmid: 9783752
references.citation: J Biol Chem. 2008 Aug 1;283(31):21441-52
references.pmid: 18534978
references.citation: Am J Hum Genet. 2007 Oct;81(4):713-25
references.pmid: 17846997
references.citation: Nature. 2000 Jan 27;403(6768):451-6
references.pmid: 10667800
references.citation: J Biol Chem. 2002 Dec 20;277(51):50160-4
references.pmid: 12364333
references.citation: Mol Cell. 2006 Jul 7;23(1):133-42
references.pmid: 16818237
references.citation: Nat Struct Biol. 2000 Dec;7(12):1125-8
references.pmid: 11101894
references.citation: Acta Crystallogr D Biol Crystallogr. 1997 May 1;53(Pt 3):240-55
references.pmid: 15299926
references.citation: Nucleic Acids Res. 2007 Jul;35(Web Server issue):W375-83
references.pmid: 17452350
references.citation: Acta Crystallogr D Biol Crystallogr. 1998 Sep 1;54(Pt 5):905-21
references.pmid: 9757107
references.citation: J Biol Chem. 2011 Nov 18;286(46):40246-54
references.pmid: 21937424
references.citation: Mol Cell. 2006 Apr 7;22(1):5-13
references.pmid: 16600865
references.citation: Proc Natl Acad Sci U S A. 1993 Jul 15;90(14):6498-502
references.pmid: 8341661
references.citation: Methods Enzymol. 1997;276:307-26
references.pmid: 27754618
references.citation: Hum Mol Genet. 2009 Oct 15;18(R2):R130-6
references.pmid: 19808788
references.citation: Nat Genet. 2006 Aug;38(8):917-20
references.pmid: 16845398
references.citation: J Biol Chem. 2008 Nov 14;283(46):31649-56
references.pmid: 18805785
references.citation: J Biol Chem. 2011 Sep 16;286(37):32373-82
references.pmid: 21808053
references.citation: Ann Rheum Dis. 2010 Oct;69(10):1886-7
references.pmid: 19875384
references.citation: J Biol Chem. 2005 Apr 15;280(15):15212-8
references.pmid: 15661738
references.citation: Acta Crystallogr D Biol Crystallogr. 1999 Oct;55(Pt 10):1718-25
references.pmid: 10531521
references.citation: Structure. 2002 Apr;10(4):535-46
references.pmid: 11937058
references.citation: Rheumatol Int. 2008 Jun;28(8):783-9
references.pmid: 18092167
references.citation: Acta Crystallogr D Biol Crystallogr. 2004 Dec;60(Pt 12 Pt 1):2126-32
references.pmid: 15572765
references.citation: Nat Genet. 2007 Sep;39(9):1068-70
references.pmid: 17660820
references.citation: Acta Crystallogr D Biol Crystallogr. 2002 Nov;58(Pt 11):1948-54
references.pmid: 12393927
references.citation: J Am Chem Soc. 2009 Feb 4;131(4):1550-6
references.pmid: 19119875
references.citation: Eur J Paediatr Neurol. 2008 Sep;12(5):355-8
references.pmid: 18343173
references.citation: Science. 1988 Apr 8;240(4849):199-201
references.pmid: 2832946
references.citation: J Biol Chem. 1999 Jul 9;274(28):19655-60
references.pmid: 10391904
references.citation: J Am Chem Soc. 2008 Aug 20;130(33):10955-62
references.pmid: 18662000
references.citation: J Biol Chem. 2006 Dec 15;281(50):38466-71
references.pmid: 16973612
references.citation: Biochem Soc Trans. 2009 Jun;37(Pt 3):535-8
references.pmid: 19442247
references.citation: Early Hum Dev. 2008 Dec;84(12):783-5
references.pmid: 18829186
references.citation: Mol Cell Biol. 2004 Aug;24(15):6719-27
references.pmid: 15254239
references.citation: EMBO J. 1999 Jul 1;18(13):3868-75
references.pmid: 10393201
references.citation: J Biol Chem. 2007 Apr 6;282(14):10537-43
references.pmid: 17293595
references.citation: Cell. 2008 Aug 22;134(4):587-98
references.pmid: 18724932
references.citation: J Biol Chem. 2007 May 11;282(19):14547-57
references.pmid: 17355961
references.citation: Structure. 2006 Apr;14(4):757-66
references.pmid: 16615916
references.citation: Biochemistry. 2004 Jun 8;43(22):6841-57
references.pmid: 15170321
references.citation: Cell. 2007 Nov 30;131(5):873-86
references.pmid: 18045533